DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Rooney CM, Smith CA, Ng CY et al.
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.
Lancet 1995;
345: 9-13
We do not assume any responsibility for the contents of the web pages of other providers.